|
|
Article: Celanese Corporation Reports Strong Third Quarter Results; Sequential Improvements in Volumes and Margins.(Financial report)
- Article from:
- Biotech Week
- Article date:
- November 11, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Celanese Corporation (NYSE: CE): Third quarter highlights: Net sales were $1,304 million, down 28% from prior year period
Operating profit was $65 million versus $151 million in prior year period
Net earnings were $399 million versus $158 million in prior year period
Operating EBITDA was $241 million versus $314 million in prior year period
Diluted EPS from continuing operations was $2.53 versus $1.01 in prior year period
Adjusted EPS was $0.58 versus $0.78 in prior year period
Three Months Ended Nine Months Ended September 30, September 30, (in $ millions, except per share data) 2009 2008 2009 2008 Net sales ...